BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH)

CUSIP: 078771300

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM NEW
Total 13F shares
1,272,937
Share change
+75,655
Total reported value
$506,560
Price per share
$0.40
Number of holders
22
Value change
+$19,287
Number of buys
7
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 078771300?
CUSIP 078771300 identifies BLPH - BELLEROPHON THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) as of Q3 2023

As of 30 Sep 2023, BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,272,937 shares. The largest 10 holders included ACADIAN ASSET MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, VANGUARD GROUP INC, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, and STATE STREET CORP. This page lists 22 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.